The Role of GeneXpert MTB/RIF in Reducing Treatment Delay Among Multidrug Resistance Tuberculosis Patients: A Propensity Score Matched Analysis

References

• World Health Organization. Global tuberculosis report 2020: executive summary; 2020.
   Google Scholar
• Kibret KT, Moges Y, Memiah P, Biadgilign S. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty. 2017;6(1):1–8. doi:10.1186/s40249-016-0214-x
   Web of Science ®Google Scholar
• Iruedo J, O’Mahony D, Mabunda S, Wright G, Cawe B. The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province. BMC Infect Dis. 2017;17(1):1–9. doi:10.1186/s12879-017-2200-8
   Web of Science ®Google Scholar
• Pooran A, Theron G, Zijenah L, et al. Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in Southern African primary care clinics: a multicentre economic evaluation. Lancet Glob Health. 2019;7(6):e798–e807. doi:10.1016/S2214-109X(19)30164-0
   Web of Science ®Google Scholar
• Meyer-Rath G, Schnippel K, Long L, et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One. 2012;7(5):e36966. doi:10.1371/journal.pone.0036966
   PubMed Web of Science ®Google Scholar
• Ershova JV, Volchenkov GV, Somova TR, et al. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia. BMC Infect Dis. 2020;20(1):1–9. doi:10.1186/s12879-020-05243-9
   Web of Science ®Google Scholar
• Schmidt B, Geldenhuys H, Tameris M, et al. Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community. S Afr Med J. 2017;107(12):1078–1081. doi:10.7196/SAMJ.2017.v107i12.12502
   Web of Science ®Google Scholar
• Castro A, Moreira AR, Oliveira J, et al. Clinical impact and cost analysis of the use of either the Xpert MTB Rif test or sputum smear microscopy in the diagnosis of pulmonary tuberculosis in Rio de Janeiro, Brazil. Rev Soc Bras Med Trop. 2018;51(5):631–637. doi:10.1590/0037-8682-0082-2018
   Web of Science ®Google Scholar
• Shiferaw MB, Yismaw G, Getachew H. Specimen rejections among referred specimens through referral network to the Amhara Public Health Institute for laboratory testing, Bahir Dar, Ethiopia. BMC Res Notes. 2018;11(1):1–6. doi:10.1186/s13104-018-3891-7
   PubMedGoogle Scholar
• Tefera KT, Mesfin N, Reta MM, Sisay MM, Tamirat KS, Akalu TY. Treatment delay and associated factors among adults with drug resistant tuberculosis at treatment initiating centers in the Amhara regional state, Ethiopia. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4112-2
   Web of Science ®Google Scholar
• Getnet F, Demissie M, Worku A, et al. Determinants of patient delay in diagnosis of pulmonary tuberculosis in Somali Pastoralist Setting of Ethiopia: a matched case-control study. Int J Environ Res Public Health. 2019;16(18):3391. doi:10.3390/ijerph16183391
   Web of Science ®Google Scholar
• Mnyambwa NP, Lekule I, Ngadaya ES, et al. Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients’ linkage to care in Tanzania. BMC Res Notes. 2018;11(1):1–6. doi:10.1186/s13104-018-3235-7
   Google Scholar
• Naidoo P, Du Toit E, Dunbar R, et al. A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town. PLoS One. 2014;9(7):e103328. doi:10.1371/journal.pone.0103328
   Web of Science ®Google Scholar
• Oga-Omenka C, Tseja-Akinrin A, Sen P, et al. Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review. BMJ Glob Health. 2020;5(7):e002280. doi:10.1136/bmjgh-2019-002280
   PubMedGoogle Scholar
• Verstraten CC, Metzelthin SF, Schoonhoven L, Schuurmans MJ, de Man‐van Ginkel JM. Optimizing patients’ functional status during daily nursing care interventions: a systematic review. Res Nurs Health. 2020;43(5):478–488. doi:10.1002/nur.22063
   Web of Science ®Google Scholar
• Izudi J, Tamwesigire IK, Bajunirwe F. Treatment supporters and level of health facility influence completion of sputum smear monitoring among tuberculosis patients in rural Uganda: a mixed-methods study. Int J Infect Dis. 2020;91:149–155. doi:10.1016/j.ijid.2019.12.003
   Web of Science ®Google Scholar
• Zhang L, Pang Y, Yu X, et al. Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerg Microbes Infect. 2016;5(1):1–11.
   Google Scholar
• Grilli L, Rampichini C. Propensity scores for the estimation of average treatment effects in observational studies. Training Sessions Causal Inference Bristol. 2011;46(3)28–29.
   Google Scholar
• Haukoos JS, Lewis RJ. The propensity score. JAMA. 2015;314(15):1637–1638. doi:10.1001/jama.2015.13480
   PubMed Web of Science ®Google Scholar
• Jacobson KR, Barnard M, Kleinman MB, et al. Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study. Clin Infect Dis. 2017;64(11):1502–1508. doi:10.1093/cid/cix128
   PubMed Web of Science ®Google Scholar
• Mozaffari A, Kianifar R. Factors affecting delay in diagnosis and treatment of pulmonary and extra pulmonary tuberculosis in Qom Province during the 2011–2017. J Med Chem Sci. 2021;4(2):100–106.
   Google Scholar
• Bieh KL, Weigel R, Smith H. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study. BMC Infect Dis. 2017;17(1):1–9. doi:10.1186/s12879-016-2114-x
   PubMed Web of Science ®Google Scholar
• Lessells RJ, Cooke GS, McGrath N, Nicol MP, Newell M-L, Godfrey-Faussett P. Impact of point-of-care Xpert MTB/RIF on tuberculosis treatment initiation. A cluster-randomized trial. Am J Respir Crit Care Med. 2017;196(7):901–910. doi:10.1164/rccm.201702-0278OC
   Web of Science ®Google Scholar
• Babirye D, Shete PB, Farr K, et al. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. J Clin Tuberc Other Mycobact Dis. 2019;16:100110. doi:10.1016/j.jctube.2019.100110
   PubMedGoogle Scholar